Jin Sun Karoline Choi

This inventor holds 12 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Arena Pharmaceuticals, Inc.. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Sun Karoline Choi. Retrieved from https://idiyas.com/inventor/jin-sun-karoline-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 6)

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 9.7

ph-index = 8

Forward Citations = 189(Granted Patents)

Company Filing History:

12 out of 218

Arena Pharmaceuticals, Inc.

patents

Years Active: 2006-2020

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10781180 - 3-phenyl-pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto (2020-09-22),

2. 10351531 - [object Object] (2019-07-16),

3. 9732039 - Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto (2017-08-15),

4. 9434692 - [object Object] (2016-09-06),

5. 8933083 - 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia (2015-01-13),

6. 8785441 - 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto (2014-07-22),

7. 8546429 - 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto (2013-10-01),

8. 8293751 - 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia (2012-10-23),

9. 7884101 - [object Object] (2011-02-08),

10. 7838525 - Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto (2010-11-23),

11. 7470699 - Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto (2008-12-30),

12. 7132426 - Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto (2006-11-07),

Title: Jin Sun Karoline Choi: Innovator in Pharmaceutical Science

Introduction

Jin Sun Karoline Choi is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds that target the serotonin receptor. With a total of 12 patents to her name, her work has the potential to impact various medical conditions.

Latest Patents

One of her latest patents involves 3-phenyl-pyrazole derivatives as modulators of the 5-HT serotonin receptor. This invention relates to certain derivatives that can be used in pharmaceutical compositions to treat disorders such as platelet aggregation, coronary artery disease, myocardial infarction, and various psychiatric disorders. The compounds are also directed towards methods useful in treating insomnia and related sleep disorders. The versatility of her inventions highlights their potential in addressing a wide range of health issues.

Career Highlights

Throughout her career, Jin Sun Karoline Choi has worked with notable companies, including Arena Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. Her innovative approach and dedication to research have positioned her as a key figure in her field.

Collaborations

She has collaborated with esteemed colleagues such as Yifeng Xiong and Robert M. Jones, contributing to the advancement of pharmaceutical research and development.

Conclusion

Jin Sun Karoline Choi's contributions to pharmaceutical science through her innovative patents and collaborations underscore her importance in the field. Her work continues to pave the way for new treatments and advancements in healthcare.

Profile summary based on public USPTO records.